Bristol-Myers Squibb Company
Adam Lenkowsky (EVP, Chief Commercial Officer) reports BMY insider transactions
AI-generated summary
Adam Lenkowsky, EVP, Chief Commercial Officer of Bristol-Myers Squibb Company, had an RSU vesting of 7,522 shares on November 3, 2026. Additionally, 3,848 shares were disposed of for tax withholding at an average price of $61.71, valued at $237,460.08. Following these transactions, the insider directly held 23,380 shares.
Key facts
- Insider
- Adam Lenkowsky · EVP, Chief Commercial Officer
| Date | Transaction | Shares | Price | Value | Held after | Ownership |
|---|---|---|---|---|---|---|
| Nov 3, 2026 | M · exercise or conversion of a derivativeFootnotes F1 | +7,522 | $0.00 | $0.00 | 27,228 | Direct |
| Nov 3, 2026 | F · tax withholdingFootnotes F2 | −3,848 | $61.71 | $237,460.08 | 23,380 | Direct |
| Nov 3, 2026 | M · exercise or conversion of a derivativeRestricted Stock UnitsFootnotes F4, F5 | −7,522 | $0.00 | $0.00 | 15,046 | Direct |
Footnotes
- F1 Represents vesting of one-third of restricted stock units granted on November 3, 2025.
- F2 Shares withheld for payment of taxes upon vesting of awards.
- F3 Based on recent 401(k) plan statement.
- F4 Each restricted stock unit converts into one share of common stock upon vesting.
- F5 The restricted stock units vest in three equal annual installments beginning on November 3, 2026.
More BMY filings
- 4
Filed Nov 3, 2026
- 4
Filed Nov 3, 2026
- 4
Filed Nov 3, 2026
- 10-Q
Filed Oct 29, 2026
- 8-K
Filed Oct 29, 2026
- 4
Filed Oct 5, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.